Sanofi and Blueprint Medicines Corporation (Blueprint), a US-based, publicly traded biopharmaceutical company specializing in systemic mastocytosis (SM), a rare immunological disease, and other KIT-driven diseases, have entered into an agreement under which Sanofi will acquire Blueprint. The acquisition includes a ra…
Mapmygenome, an AI-driven leader in genomics and personalized health, announced the strategic acquisition of Microbiome Insights, a global leader in microbial sequencing. The acquisition includes Microbiome Insights' CAP-accredited Canadian laboratory and rich intellectual property, boosting Mapmygenome's scientific p…
BioIVT, a global research partner and biospecimen solutions provider for drug and diagnostic development, announced an exclusive commercial agreement with Handok Biotech Co. LTD., which will allow Handok to offer researchers in South Korea access to a wider range of high-quality, innovative products. The strategic all…
Cariflex Pte. Ltd, the global market leader in polyisoprene rubber latex for medical-end markets and wholly owned subsidiary of DL Chemical Co., Ltd. (DL Chemical), officially inaugurated its new polyisoprene latex plant at Jurong Island, Singapore today. With an investment of US$355 million, the plant is the largest …
In a groundbreaking move, Gene Solutions, a leader in prenatal and oncology genetic testing, and NEWCL Biomedical Laboratory, Taiwan's pioneering clinical laboratory with LDTs certification, have joined forces to establish an advanced Next-Generation Sequencing (NGS) laboratory in Taiwan. This collaboration was sealed…
Xellia Pharmaceuticals, a global leader in the manufacturing of fermentation-based anti-infective active pharmaceutical ingredients (APIs), announced plans for a gradual closure and transition of its manufacturing operations in Copenhagen, Denmark, to facilities outside of Denmark. The phased migration of the company’…
Dawn Health, a global leader in digital health, has secured a funding round of €11.5 million from its existing investors: Chr. Augustinus Fabrikker, the Export and Investment Fund of Denmark (EIFO), and Trifork. The investment is aimed at supporting the company's strategy to deliver its platform and product suite to g…
CellBio Scientific, a premier provider of life science tools, research services, and clinical solutions, announced the acquisition of BioChain, a leading provider of biospecimen collection, preparation, and analysis. The acquisition strengthens CellBio Scientific's platform at a pivotal moment in drug discovery and d…
Oramed Pharmaceuticals Inc., a platform technology pioneer in the field of oral delivery solutions for drugs currently delivered via injection, announced that it has successfully closed a strategic investment in Alpha Tau Medical Ltd., the developer of the innovative alpha-radiation cancer therapy Alpha DaRT. As part…
Jazz Pharmaceuticals plc announced the successful completion of its acquisition of Chimerix, Inc. ("Chimerix") for approximately $935 million in cash. Chimerix is now a wholly owned subsidiary of Jazz. "Bringing Chimerix into Jazz adds a novel medicine to our oncology portfolio and advances our efforts to address unm…
Page 33 of 36